Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Alfa Wassermann and Merckle sign development and marketing agreement for rifaximin

June 12, 1997

Successful phase III trials of Cytolex trigger milestone payment for Magainin

June 11, 1997

Peptidomimetic inhibitors of fungal NMT prepared by Searle

June 10, 1997

Micrologix Biotech enhancin restores activity of vancomycin

June 10, 1997

New antibacterial agents described by Zeneca

June 10, 1997

Generic aciclovir approved by FDA

June 9, 1997

In vitro activity of MEN-10700 assessed

June 5, 1997

3M to launch Aldara next week

June 5, 1997

Interferon Sciences announces distribution agreement for Alferon N Injection

June 3, 1997

Molecular structure of prostaglandins responsible for HSF1 activation elucidated

June 2, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 7, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 7, 2024.
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...
Sanofi bets on Resalis’ oligonucleotide RES-010 for obesity
BioWorld
After missing out on the glucagon-like peptide 1 obesity market, Sanofi SA is prospecting for next-generation drugs and is making a strategic equity investment in...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.